An Investigational Drug Study in Obese (Considerably Overweight) Patients (0364-006)

Phase 2

Completed

• Conditions: Obesity

• Registration Number: NCT00109148
• Lead Sponsor: Merck Sharp & Dohme LLC

Brief Summary

The purpose of this study is to determine the safety and effectiveness of an investigational drug in patients with obesity (considerably overweight).

Detailed Description

Not available

Study Timeline

• Study Start: 2004-07
• Primary Completion: 2005-01
• Study Completion: 2005-02
• Study First Submitted: 2005-04-22
• Study First Submitted QC: 2005-04-22
• Study First Posted: 2005-04-25
• Status Verified: 2015-09
• Last Update Submitted: 2015-09-08
• Last Update Posted: 2015-09-09

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 500

Inclusion Criteria

• Patients who are obese (considerably overweight) based on body mass index.

Exclusion Criteria

• Patients with serious or unstable current or past medical conditions

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL